Research Output per year
Fingerprint Dive into the research topics where M. Aleksza is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 21 Similar Profiles
T-Lymphocytes
Medicine & Life Sciences
Systemic Lupus Erythematosus
Medicine & Life Sciences
Cytokines
Medicine & Life Sciences
Interleukin-4
Medicine & Life Sciences
Interleukin-10
Medicine & Life Sciences
Regulatory T-Lymphocytes
Medicine & Life Sciences
Plasmapheresis
Medicine & Life Sciences
Mixed Connective Tissue Disease
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2000 2016
- 789 Citations
- 18 h-Index
- 36 Article
7
Citations
(Scopus)
Guanosine may increase absence epileptic activity by means of A2A adenosine receptors in Wistar Albino Glaxo Rijswijk rats
Lakatos, R. K., Dobolyi, A., Todorov, M. I., Kékesi, K., Juhász, G., Aleksza, M. & Kovács, Z., Jun 1 2016, In : Brain Research Bulletin. 124, p. 172-181 10 p.Research output: Contribution to journal › Article
Adenosine A2A Receptors
Guanosine
Absence Epilepsy
Intraperitoneal Injections
Anticonvulsants
6
Citations
(Scopus)
Antiphospholipid antibodies in relation to sterility/infertility
Kovács, M., Hartwig, M., Aleksza, M., Tihanyi, M., Nagy, T., Vajda, G., Daru, J. & Gasztonyi, B., Jul 2012, In : Human Immunology. 73, 7, p. 726-731 6 p.Research output: Contribution to journal › Article
Antiphospholipid Antibodies
Infertility
Antiphospholipid Syndrome
Spontaneous Abortion
Autoimmune Diseases
15
Citations
(Scopus)
Combined plasmapheresis and high-dose intravenous immunoglobulin treatment in systemic sclerosis for 12 months: Follow-up of immunopathological and clinical effects
Szekanecz, Z., Aleksza, M., Antal-Szalmás, P., Soltész, P., Veres, K., Szántó, S., Szabó, Z., Végvári, A., Szamosi, S., Lakos, G., Sipka, S., Szegedi, G., Varga, J. & Szűcs, G., 2009, In : Clinical Rheumatology. 28, 3, p. 347-350 4 p.Research output: Contribution to journal › Article
Plasmapheresis
Systemic Scleroderma
Intravenous Immunoglobulins
Therapeutics
Diffuse Scleroderma